Insider trades

Ron Martell, CEO of Jasper Therapeutics JSPR, has filed 1 purchase and 0 sales on the open market. The latest trade was on 01/02.

Ron Martell

President, CEO and Director
First filing
23/02/03
Trades
12 trades
Buys / sales
1 / 0
12-month net buying
No record
Last trade
01/02

Trading activity

Transactions

Trade type
Open-market buy25/09/2225/09/2441,000 sh$2.43$99,630+123.8%